Safety of Lopinavir/Ritonavir (Kaletra) in HIV/HCV Co-infected Subjects vs Baseline Liver Biopsy Metavir Score

NCT00234975 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

86

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infection

Interventions

DRUG: Lopinavir/Ritonavir

Sponsor

AbbVie (prior sponsor, Abbott)